Response to Dr Minota's Letter to the Editor of Modern Rheumatology Regarding a Study of Tofacitinib in Japanese Patients with Rheumatoid Arthritis

"Response to Dr Minota's Letter to the Editor of Modern Rheumatology Regarding a Study of Tofacitinib in Japanese Patients with Rheumatoid Arthritis." Modern Rheumatology, 26(2), pp. 318–319

This article is related to:

IL-18 serum concentration is markedly elevated in typical familial Mediterranean fever with M694I mutation and can distinguish it from atypical type

Conflict of interest

Y. Tanaka has received consulting fees, speaking fees, and/or honoraria from Abbvie, Chugai, Astellas, Takeda, Santen, Mitsubishi-Tanabe, Pfizer, Janssen, Eisai, Daiichi-Sankyo, UCB, GlaxoSmithKline, and Bristol-Myers; and has received research grants from Mitsubishi-Tanabe, Chugai, MSD, Astellas, and Novartis. SH Zwillich is a Pfizer employee. This study was sponsored by Pfizer.